These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


670 related items for PubMed ID: 15316862

  • 1. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M, Amano S.
    J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
    [Abstract] [Full Text] [Related]

  • 2. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
    Lossdörfer S, Schwartz Z, Wang L, Lohmann CH, Turner JD, Wieland M, Cochran DL, Boyan BD.
    J Biomed Mater Res A; 2004 Sep 01; 70(3):361-9. PubMed ID: 15293309
    [Abstract] [Full Text] [Related]

  • 7. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.
    J Cell Physiol; 2005 Jun 01; 203(3):573-82. PubMed ID: 15573398
    [Abstract] [Full Text] [Related]

  • 8. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH, Chang EJ, Kim SJ, Kim HH, Kim HM, Lee SB, Ko JS.
    J Periodontal Res; 2006 Aug 01; 41(4):288-96. PubMed ID: 16827722
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
    Takasu H, Sugita A, Uchiyama Y, Katagiri N, Okazaki M, Ogata E, Ikeda K.
    J Clin Invest; 2006 Feb 01; 116(2):528-35. PubMed ID: 16424941
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S, Yamaguchi M.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1297-305. PubMed ID: 15013845
    [Abstract] [Full Text] [Related]

  • 15. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF).
    Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):697-702. PubMed ID: 9837769
    [Abstract] [Full Text] [Related]

  • 16. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF, Lie A, Ransjö M.
    J Cell Biochem; 2006 Oct 01; 99(2):528-37. PubMed ID: 16639710
    [Abstract] [Full Text] [Related]

  • 17. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T.
    Endocrinology; 2000 Sep 01; 141(9):3478-84. PubMed ID: 10965921
    [Abstract] [Full Text] [Related]

  • 18. Osteoclastogenesis is decreased by cysteine proteinase inhibitors.
    Brage M, Lie A, Ransjö M, Kasprzykowski F, Kasprzykowska R, Abrahamson M, Grubb A, Lerner UH.
    Bone; 2004 Mar 01; 34(3):412-24. PubMed ID: 15003789
    [Abstract] [Full Text] [Related]

  • 19. Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand.
    Xu J, Tan JW, Huang L, Gao XH, Laird R, Liu D, Wysocki S, Zheng MH.
    J Bone Miner Res; 2000 Nov 01; 15(11):2178-86. PubMed ID: 11092398
    [Abstract] [Full Text] [Related]

  • 20. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.